Project Grant R21AI193739
Award Date 8/21/25
Completion Date 7/31/27
Dollars Obligated $242K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Davis, CA, USA
Similar Awards
- This $233,250 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to optimize culture and metagenomic methods to detect multi-strain Clostridioides difficile (C. difficile) colonization and infection. The 2-year project seeks to enhance the recovery of multiple and cryptic C. difficile strains from stool samples by employing a combination of culture conditions. Additionally, the project will...
- This $894,552 project grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases Allergy and Infectious Diseases Research program (CFDA 93.855) will fund research at the University of Nevada, Las Vegas to probe the effect of a high-fat/high-protein diet on Clostridioides difficile infection. Specifically, the researchers will examine how such a diet impacts inflammation, intestinal permeability, and the gut microbiome before and after antibiotic...
- The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), awarded a $136,104 Project Grant to Tufts University School of Medicine. The grant, awarded on October 24, 2025, will support research to investigate the effect of Clostridioides difficile's (C. difficile) spatial distribution and toxin gene expression within the colon on disease severity. The research will utilize fluorescent reporter strains...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $511,553 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Maryland, Baltimore. The grant funding will support the development of an oral immunotherapy using engineered probiotic yeast to deliver neutralizing antibodies against the Clostridioides difficile (C. diff) surface protein CWP84. This novel approach aims to reduce C. diff colonization and spore...
- This Project Grant award, valued at $184,651, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855). The award will support research at Duke University focused on improving the understanding of the progression from Clostridioides difficile (C. difficile) carriage to active infection. Specifically, the research aims to: 1) Identify metagenomic and metabolomic risk factors present...
- This $661,693 federal Project Grant awarded by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to define the structure and function of a new family of peptidoglycan crosslinking enzymes in the opportunistic pathogen Clostridioides difficile. The research aims to advance understanding of C. difficile's cell wall composition and enzymes essential for its survival and virulence, with the potential to inform the...
- This federal Project Grant award of $195,213 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research by the University of California, Davis to investigate the mechanisms by which the gut microbiota, specifically short-chain fatty acids, can inhibit the growth of the enteric pathogen Yersinia enterocolitica. The research aims to elucidate the molecular mechanisms underlying Y. enterocolitica's sensitivity and...
- This Project Grant award of $2,872,722 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to elucidate the role of penicillin-binding proteins (PBPs) in the Clostridioides difficile life cycle and develop new PBP inhibitors to target C. difficile sporulation. The research aims to enhance the understanding of PBPs across bacterial species and provide new insights into the unique...
- This is a $300,892 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The grant supports research by the University of North Carolina at Chapel Hill to identify and annotate Rho, NusA, and NusG dependent transcriptional terminators in Clostridioides difficile. The objective is to determine how these factors regulate the expression of key virulence genes involved in C. difficile...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $136,050 to Tufts University School of Medicine to conduct research on the mechanisms that control Clostridioides difficile spore germination. The research aims to understand how C. difficile, which lacks traditional germinant receptors found in other spore-forming bacteria, uses two pseudoprotease enzymes, CspA and...